mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for NTRK2
Gene summary
Basic gene Info.Gene symbolNTRK2
Gene nameneurotrophic tyrosine kinase, receptor, type 2
SynonymsGP145-TrkB|TRKB|trk-B
CytomapUCSC genome browser: 9q22.1
Type of geneprotein-coding
RefGenesNM_001007097.2,
NM_001018064.2,NM_001018065.2,NM_001018066.2,NM_001291937.1,
NM_006180.4,
DescriptionBDNF-tropomyosine receptor kinase BBDNF/NT-3 growth factors receptortropomyosin-related kinase Btyrosine kinase receptor B
Modification date20141222
dbXrefs MIM : 600456
HGNC : HGNC
Ensembl : ENSG00000148053
HPRD : 02712
Vega : OTTHUMG00000020120
ProteinUniProt: Q16620
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_NTRK2
BioGPS: 4915
PathwayNCI Pathway Interaction Database: NTRK2
KEGG: NTRK2
REACTOME: NTRK2
Pathway Commons: NTRK2
ContextiHOP: NTRK2
ligand binding site mutation search in PubMed: NTRK2
UCL Cancer Institute: NTRK2
Assigned class in mutLBSgeneDBA: This gene has a literature evidence and it belongs to targetable_mutLBSgenes.
References showing study about ligand binding site mutation for NTRK2.1. Gray, J., Yeo, G., Hung, C., Keogh, J., Clayton, P., Banerjee, K., ... & Farooqi, I. S. (2007). Functional characterization of human NTRK2 mutations identified in patients with severe early-onset obesity. International journal of obesity, 31(2), 359-364. 16702999

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for NTRK2
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
F672,H674V673MBRCA1
H674R675HCOAD1
L544E543GCOAD1
K572T573IGBM1
L544E543DLUAD1
L544G545SLUAD1
H674R675COV1
M620M620VSTAD1
V601K602TSTAD1
F672,H674V673MUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for NTRK2
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
L544E543G-1.507436
L544E543D-1.3493145
F672V673M-1.3446437
H674V673M-1.3446437
M620M620V-0.88280745
V601K602T-0.61297888
K572T573I-0.51013746
H674R675H-0.47887189
L544G545S-0.36138778
H674R675C-0.23076928
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for NTRK2 from PDB

Top
Differential gene expression and gene-gene network for NTRK2
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of NTRK2 and the right PPI network was created from samples without mutations in the LBS of NTRK2. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for NTRK2
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C0027819Neuroblastoma11Biomarker
umls:C0028754Obesity5Biomarker
umls:C0005586Bipolar Disorder3Biomarker, GeneticVariation
umls:C0004352Autistic Disorder2Biomarker, GeneticVariation
umls:C0020505Hyperphagia2Biomarker
umls:C0236736Cocaine-Related Disorders2Biomarker
umls:C0424295Hyperkinesis2Biomarker
umls:C0038220Status Epilepticus2Biomarker
umls:C3151303Obesity, Hyperphagia, and Developmental Delay1GeneticVariation
umls:C0004114Astrocytoma1Biomarker
umls:C0008073Developmental Disabilities1Biomarker
umls:C0017638Glioma1Biomarker
umls:C0752347Lewy Body Disease1Biomarker

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for NTRK2
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.

Gene-centered drug-gene interaction network
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure
ApprovedDB00321AmitriptylineSmall molecule

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of NTRK2 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS


Top
Conservation information for LBS of NTRK2
Multiple alignments for Q16620 in multiple species
LBSAA sequence# speciesSpecies
A570DKILVAVKTLK4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
D694LVKIGDFGMSR4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
E588KDFHREAELLT4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
E618LIMVFEYMKHG4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
F549LGEGAFGKVFL4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
F617PLIMVFEYMKH4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
F672LASQHFVHRDL4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
F695VKIGDFGMSRD4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
G623EYMKHGDLNKF4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
G693LLVKIGDFGMS4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
H674SQHFVHRDLAT4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
I600LQHEHIVKFYG4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
I692NLLVKIGDFGM4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
K572ILVAVKTLKDA4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
K621VFEYMKHGDLN4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
L544VLKRELGEGAF4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
L592REAELLTNLQH4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
L595ELLTNLQHEHI4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
L683ATRNCLVGENL4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
M620MVFEYMKHGDL4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
N681DLATRNCLVGE4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
V601QHEHIVKFYGV4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
Y619IMVFEYMKHGD4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas